Click here to get full coverage on OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment - Yahoo Finance

OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment  Yahoo Finance

OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment - Yahoo Finance

Click here to get full coverage on Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News - Quiver Quantitative

Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News  Quiver Quantitative

Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News - Quiver Quantitative

Click here to get full coverage on Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

Here's Why You Should Hold OPK Stock in Your Portfolio for Now  Yahoo Finance

Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

Click here to get full coverage on Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation - Yahoo Finance

Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation  Yahoo Finance

Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation - Yahoo Finance

Click here to get full coverage on Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Yahoo Finance

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development  Yahoo Finance

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Yahoo Finance

Click here to get full coverage on Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns - Yahoo Finance

Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns  Yahoo Finance

Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week - Yahoo Finance

OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week  Yahoo Finance

OPKO Health (NASDAQ:OPK investor five-year losses grow to 58% as the stock sheds US$64m this past week - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade - Yahoo Finance

The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade  Yahoo Finance

The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade - Yahoo Finance

Click here to get full coverage on Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance

Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates  Yahoo Finance

Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance

Click here to get full coverage on How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance

How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals  Yahoo Finance

How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance

Click here to get full coverage on 44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance

44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently  Yahoo Finance

44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance

Click here to get full coverage on Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands  Yahoo Finance

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance

Click here to get full coverage on Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance - Yahoo Finance

Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance  Yahoo Finance

Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance

OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla  Yahoo Finance

OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance

Click here to get full coverage on OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts  Yahoo Finance

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance

Click here to get full coverage on Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - Yahoo Finance

Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals  Yahoo Finance

Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - Yahoo Finance

Click here to get full coverage on OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - Yahoo Finance

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands  Yahoo Finance

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - Yahoo Finance

Click here to get full coverage on Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance

Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)?  Yahoo Finance

Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance

Click here to get full coverage on Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld News

Opko’s OPK-88006 shows hepatoprotection in MASH  BioWorld News

Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld News

Click here to get full coverage on OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics - Yahoo Finance

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics  Yahoo Finance

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics - Yahoo Finance

Click here to get full coverage on Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy - Yahoo Finance

Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy  Yahoo Finance

Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy - Yahoo Finance

Click here to get full coverage on OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha

OPKO Health: The Waiting Game Continues (NASDAQ:OPK)  Seeking Alpha

OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance

OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings  Yahoo Finance

OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance

Click here to get full coverage on OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Analysts - MarketBeat

OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Analysts  MarketBeat

OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Analysts - MarketBeat

Click here to get full coverage on A new COVID antibody enters human testing for high-risk adults - Stock Titan

A new COVID antibody enters human testing for high-risk adults  Stock Titan

A new COVID antibody enters human testing for high-risk adults - Stock Titan

Click here to get full coverage on OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK) - Seeking Alpha

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)  Seeking Alpha

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - simplywall.st

OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives  simplywall.st

OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - simplywall.st

Click here to get full coverage on OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - simplywall.st

OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up  simplywall.st

OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - simplywall.st

Click here to get full coverage on OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan

OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17  Stock Titan

OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan

Click here to get full coverage on Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook? - simplywall.st

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook?  simplywall.st

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook? - simplywall.st

Click here to get full coverage on OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results  OPKO Health, Inc.

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

Click here to get full coverage on A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30 - simplywall.st

A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30  simplywall.st

A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30 - simplywall.st

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened - MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened  MarketBeat

OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Here's What Happened - MarketBeat

Click here to get full coverage on OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance

OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1  Yahoo Finance

OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance

Click here to get full coverage on OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update - Stock Titan

OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update  Stock Titan

OPKO Health inks $1B-plus Regeneron antibody pact in Q4 update - Stock Titan

Click here to get full coverage on Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com

Opko Health CEO Phillip Frost buys $737,747 in OPK stock  Investing.com

Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com

Click here to get full coverage on Daily oral PTH tablet targets relief from hypoparathyroidism injections - Stock Titan

Daily oral PTH tablet targets relief from hypoparathyroidism injections  Stock Titan

Daily oral PTH tablet targets relief from hypoparathyroidism injections - Stock Titan

Click here to get full coverage on OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26  OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.

Click here to get full coverage on Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now  Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule - Stock Titan

OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule  Stock Titan

OPKO Health (NASDAQ: OPK) in Regeneron deal: $7M upfront, up to $200M per molecule - Stock Titan

Click here to get full coverage on Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares - simplywall.st

Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares  simplywall.st

Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares - simplywall.st

Click here to get full coverage on Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025? - simplywall.st

Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025?  simplywall.st

Does OPKO Health’s Recent Rebound Signal a Mispriced Opportunity in 2025? - simplywall.st

Click here to get full coverage on 5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing - The Bump

5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing  The Bump

5 Best Ovulation Tests to Find Your Fertile Days, Based on Our Testing - The Bump

Click here to get full coverage on OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan

OPKO Health (NASDAQ: OPK) director reports initial common stock holdings  Stock Titan

OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan

Click here to get full coverage on Phillip Frost adds OPKO shares; indirect stake tops 214.9M - Stock Titan

Phillip Frost adds OPKO shares; indirect stake tops 214.9M  Stock Titan

Phillip Frost adds OPKO shares; indirect stake tops 214.9M - Stock Titan

Click here to get full coverage on OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan

OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board  Stock Titan

OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan

Click here to get full coverage on OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations | OPK Stock News - Quiver Quantitative

OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations | OPK Stock News  Quiver Quantitative

OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations | OPK Stock News - Quiver Quantitative

Click here to get full coverage on OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK) - Seeking Alpha

OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK)  Seeking Alpha

OPKO Health: The Lab Sale Brings Focus, But Execution Still Key (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week  simplywall.st

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Click here to get full coverage on Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Insider Monkey

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development  Insider Monkey

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Insider Monkey

Click here to get full coverage on OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - OPKO Health, Inc.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit  OPKO Health, Inc.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - OPKO Health, Inc.

Click here to get full coverage on Income Statement - OPKO Health, Inc.

Income Statement - OPKO Health, Inc.

Click here to get full coverage on Compared to estimates, OPKO Health (OPK) Q4 earnings: A look at key metrics - MSN

Compared to estimates, OPKO Health (OPK) Q4 earnings: A look at key metrics  MSN

Compared to estimates, OPKO Health (OPK) Q4 earnings: A look at key metrics - MSN

Click here to get full coverage on OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - OPKO Health, Inc.

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference  OPKO Health, Inc.

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - OPKO Health, Inc.

Click here to get full coverage on OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results  Yahoo Finance

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

Click here to get full coverage on Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting - Chatham House

Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting  Chatham House

Russia’s struggle to modernize its military industry | The impact of sanctions and war, and how the OPK is adapting - Chatham House

Click here to get full coverage on With OPKO Health Stock Sliding, Have You Assessed The Risk? - Trefis

With OPKO Health Stock Sliding, Have You Assessed The Risk?  Trefis

With OPKO Health Stock Sliding, Have You Assessed The Risk? - Trefis

Click here to get full coverage on A Look at OPKO Health (OPK) Valuation Following Regeneron Deal, Oncology Sale, and Earnings Surprise - Sahm

A Look at OPKO Health (OPK) Valuation Following Regeneron Deal, Oncology Sale, and Earnings Surprise  Sahm

A Look at OPKO Health (OPK) Valuation Following Regeneron Deal, Oncology Sale, and Earnings Surprise - Sahm

Click here to get full coverage on BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK) - Sahm

BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK)  Sahm

BioReference Lab Sale Might Change The Case For Investing In OPKO Health (OPK) - Sahm

Click here to get full coverage on Here's Why You Should Retain OPKO Health Stock in Your Portfolio - Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio  Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - Yahoo Finance

Click here to get full coverage on OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025 - Quiver Quantitative

OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025  Quiver Quantitative

OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025 - Quiver Quantitative

Click here to get full coverage on OPKO Health to Report Second Quarter 2025 Financial Results on July 31 - OPKO Health, Inc.

OPKO Health to Report Second Quarter 2025 Financial Results on July 31  OPKO Health, Inc.

OPKO Health to Report Second Quarter 2025 Financial Results on July 31 - OPKO Health, Inc.

Click here to get full coverage on OPKO Health (OPK) Q4 2025 Earnings Call Transcript - AOL.com

OPKO Health (OPK) Q4 2025 Earnings Call Transcript  AOL.com

OPKO Health (OPK) Q4 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Oral dual GLP-1/glucagon receptor agonist peptide shows favorable preclinical profile - BioWorld News

Oral dual GLP-1/glucagon receptor agonist peptide shows favorable preclinical profile  BioWorld News

Oral dual GLP-1/glucagon receptor agonist peptide shows favorable preclinical profile - BioWorld News

Click here to get full coverage on OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada

OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus  Investing.com Canada

OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada

Click here to get full coverage on Here's Why You Should Add OPKO Health Stock to Your Portfolio - Zacks Investment Research

Here's Why You Should Add OPKO Health Stock to Your Portfolio  Zacks Investment Research

OPK

Price Chart

Key Statistics

Technicals

About OPK

Latest News

OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment - Yahoo Finance

Insider Purchase: CEO & Chairman of $OPK Buys 155,496 Shares | OPK Stock News - Quiver Quantitative

Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers